In Silico Rational Design and Immunoinformatic Analysis of a Multi-Epitope Peptide Vaccine Targeting Neuroinflammatory Pathways in Migraine
Abstract
Migraine is a major neurovascular disorder affecting millions of people globally with the current therapies which are not limited to the long-term prevention. The chronic Neuroinflammation which is a symptom of migraine. This involves pathways which are linked by the CGRP, PACAP, and TRPV which are linked to the Neuroinflammation and pain signalling. Our study aims the development of the multi epitope based peptide vaccine candidates which are protein driven primarily targeting the CGRP as the primary target. As cgrp is the key target protein in the migraine management. In this study we have targeted the key target proteins and analysed their physiochemical properties and epitopes were screened and screened epitopes were identified with the toxicity, allergenicity, antigenicity, followed by the vaccine constructs using the linkers and adjuvants. The tertiary structures were identified and the molecular docking was performed with the tlr3, tlr4, and tlr6. The final vaccine construct which was screened exhibited the high immunogenicity, stability, and non-allergenicity is observed.
Read the paper
Related studies
- Calcium Ions in the Physiology and Pathology of the Central Nervous System
- AI-powered in silico twins: redefining precision medicine through simulation, personalization, and predictive healthcare
- In silico functional, structural and pathogenicity analysis of missense single nucleotide polymorphisms in human MCM6 gene
- In Silico drug repurposing pipeline using deep learning and structure based approaches in epilepsy
- Targeting serotonin receptors with phytochemicals – an in-silico study
- In silico exploration of anti-prostate cancer compounds from differential expressed genes
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.